In consultation: Guidance and quality standards
Showing 11 to 15 of 15
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325] | Final draft guidance | Technology appraisal guidance | |
| Digital technologies to support self-management of asthma: early value assessment | Draft guidance | Health technology evaluation | |
| Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over ID6542 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Guidance on the use of electroconvulsive therapy | Review proposal consultation | Technology appraisal guidance | |
| Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people 1 year and over ID6400 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |